179 related articles for article (PubMed ID: 36945431)
1. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
[TBL] [Abstract][Full Text] [Related]
3. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
[TBL] [Abstract][Full Text] [Related]
4. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.
Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
J Virol; 2021 Jul; 95(15):e0076621. PubMed ID: 34011547
[TBL] [Abstract][Full Text] [Related]
5. The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD
Stevens LA; Kato J; Kasamatsu A; Oda H; Lee DY; Moss J
ACS Chem Biol; 2019 Dec; 14(12):2576-2584. PubMed ID: 31599159
[TBL] [Abstract][Full Text] [Related]
6. Mutation of highly conserved residues in loop 2 of the coronavirus macrodomain demonstrates that enhanced ADP-ribose binding is detrimental to infection.
Kerr CM; Pfannenstiel JJ; Alhammad YM; Roy A; O'Connor JJ; Ghimire R; Khattabi R; Shrestha R; McDonald PR; Gao P; Johnson DK; More S; Channappanavar R; Fehr AR
bioRxiv; 2024 Jan; ():. PubMed ID: 38260573
[TBL] [Abstract][Full Text] [Related]
7. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780
[TBL] [Abstract][Full Text] [Related]
8. An MHV macrodomain mutant predicted to lack ADP-ribose binding activity is severely attenuated, indicating multiple roles for the macrodomain in coronavirus replication.
Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
bioRxiv; 2021 Mar; ():. PubMed ID: 33821264
[TBL] [Abstract][Full Text] [Related]
9. ARH Family of ADP-Ribose-Acceptor Hydrolases.
Ishiwata-Endo H; Kato J; Yamashita S; Chea C; Koike K; Lee DY; Moss J
Cells; 2022 Nov; 11(23):. PubMed ID: 36497109
[TBL] [Abstract][Full Text] [Related]
10. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
11. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature.
Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
Sci Adv; 2022 May; 8(21):eabo5083. PubMed ID: 35622909
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
Michalska K; Kim Y; Jedrzejczak R; Maltseva NI; Stols L; Endres M; Joachimiak A
IUCrJ; 2020 Sep; 7(Pt 5):814-824. PubMed ID: 32939273
[TBL] [Abstract][Full Text] [Related]
14. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.
Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
Bioorg Med Chem; 2022 Aug; 67():116788. PubMed ID: 35597097
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and X-ray diffraction at room temperature.
Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
bioRxiv; 2022 Feb; ():. PubMed ID: 35169801
[TBL] [Abstract][Full Text] [Related]
17. An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors.
O'Connor JJ; Ferraris D; Fehr AR
Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887737
[TBL] [Abstract][Full Text] [Related]
18. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
bioRxiv; 2022 Mar; ():. PubMed ID: 35262075
[TBL] [Abstract][Full Text] [Related]
19. PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
Kerr CM; Parthasarathy S; Schwarting N; O'Connor JJ; Pfannenstiel JJ; Giri E; More S; Orozco RC; Fehr AR
J Virol; 2023 Sep; 97(9):e0088523. PubMed ID: 37695054
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.
Alhammad YM; Parthasarathy S; Ghimire R; O'Connor JJ; Kerr CM; Pfannenstiel JJ; Chanda D; Miller CA; Unckless RL; Zuniga S; Enjuanes L; More S; Channappanavar R; Fehr AR
bioRxiv; 2023 Apr; ():. PubMed ID: 37066301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
